• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LLC - IRVINE TECHNOLOGY CENTER CENTURION VISION SYSTEM; UNIT, PHACOFRAGMENTATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LLC - IRVINE TECHNOLOGY CENTER CENTURION VISION SYSTEM; UNIT, PHACOFRAGMENTATION Back to Search Results
Model Number ASKU
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Conjunctivitis (1784); Inflammation (1932); Uveitis (2122); Vitritis (2181); Toxic Anterior Segment Syndrome (TASS) (4469)
Event Date 05/05/2021
Event Type  Injury  
Manufacturer Narrative
Investigation including root cause analysis is in progress.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.This is the first of six reports for this reported patient event.The manufacturer internal reference number is: (b)(4).
 
Event Description
A surgeon reported a patient experienced toxic anterior segment syndrome (tass) following a cataract extraction procedure.The patient presented post-operative day one with more anterior chamber reaction.Upon examination of the patient, the surgeon noted 2+ aqueous cell, less than 1+ conjunctival inflammation and less than 1+ vitreous inflammation.No cultures were performed.The patient's symptoms have resolved without any additional treatment.This report represents the second of three patients for this surgeon.
 
Manufacturer Narrative
There were no samples returned for evaluation.There was no further information provided by this customer.With no additional, related information provided.The customer reported event was not able to be confirmed.Based on the information obtained, the root cause of the reported events cannot be determined conclusively.Data will continue to be monitored for evidence of adverse trending and take further action as appropriate.The manufacturer internal reference number is: (b)(4).
 
Manufacturer Narrative
Corrected information provided.The manufacturer internal reference number is: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CENTURION VISION SYSTEM
Type of Device
UNIT, PHACOFRAGMENTATION
Manufacturer (Section D)
ALCON RESEARCH, LLC - IRVINE TECHNOLOGY CENTER
15800 alton parkway
irvine CA 92618
MDR Report Key12087048
MDR Text Key259375572
Report Number2028159-2021-00692
Device Sequence Number1
Product Code HQC
Combination Product (y/n)N
PMA/PMN Number
K121555
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup,Followup
Report Date 09/29/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberASKU
Device Catalogue NumberASKU
Device Lot NumberASKU
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 06/07/2021
Initial Date FDA Received06/29/2021
Supplement Dates Manufacturer Received08/04/2021
09/03/2021
Supplement Dates FDA Received08/20/2021
09/29/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
BALANCED SALT SOLUTION.; BESIVANCE.; BIOGEL GLOVE.; CENTURION PROCEDURE PAK.; CLEARCUT INTREPID KNIVES.; CUSTOM-PAK PROCEDURE PACK.; DUOVISC VISCOELASTIC SYSTEM.; INTRACAMERAL LIDOCAINE.; INTREPID DISPOSABLE I/A SET.; OCUFLOX.; PCB00 (TECNIS IOL).; PHENYLEPHRINE.; POVIDONE IODINE.; PROTEXIS GLOVE.; TETRACAINE HYDROCHLORIDE.; TROPICAMIDE.; TYLENOL.; ULTRATOUCH GLOVE.; XYLOCAINE.
Patient Outcome(s) Other;
Patient Age72 YR
-
-